Literature DB >> 3819260

Gram-negative bacillary bacteremia in the elderly: incidence, ecology, etiology, and mortality.

J D McCue.   

Abstract

The incidence, ecology, and mortality of gram-negative bacillary bacteremia in elderly patients were studied in an analysis of 334 episodes over a four-year-period in a 489-bed North Carolina community teaching hospital, 135 (40.4%) of which occurred in patients 70 years of age or older. The bacteremia rate per 1000 hospital admissions increased sharply with increasing age. The ecology and in vitro antimicrobial susceptibilities of the bacterial isolates were strongly influenced by community v hospital acquisition, but not by age. Urosepsis was significantly more likely to be the underlying source of hospital-acquired bacteremia in patients 70 years or older (P less than 0.01). Total bacteremia-related mortality did not increase with increasing age; in the group of patients aged 70 years or older with nonfatal/ultimately fatal underlying diseases (NF/UFUD), however, mortality was 9.1% compared to 2.9% in the younger age group (P less than 0.001). Significantly increased bacteremia-related mortality was also noted in the older patients with NF/UFUD admitted from nursing homes (P less than 0.05) and those not treated with an appropriate antimicrobial agent within 24 hours (P less than 0.01). Overall, the older patients with hospital-acquired bacteremia, neutropenia-associated infection, those bacteremic from a nonurinary source of infection, and those treated with multiple-drug regimens had higher mortality (P less than 0.05). Gram-negative bacteremia is much more common in patients 70 years of age or older and compared with younger patients mortality appears to be significantly increased for the important subgroup of older patients with nonfatal or ultimately fatal underlying diseases.

Entities:  

Mesh:

Year:  1987        PMID: 3819260     DOI: 10.1111/j.1532-5415.1987.tb02311.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  14 in total

Review 1.  Bloodstream infections in older patients.

Authors:  Dafna Yahav; Noa Eliakim-Raz; Leonard Leibovici; Mical Paul
Journal:  Virulence       Date:  2015-12-18       Impact factor: 5.882

2.  Bacteremic and non-bacteremic febrile urinary tract infection--a review of 168 hospital-treated patients.

Authors:  M Jerkeman; J H Braconier
Journal:  Infection       Date:  1992 May-Jun       Impact factor: 3.553

3.  Bacteremia in nursing home patients. Prevalence among patients presenting to an emergency department.

Authors:  D Sinclair; A Svendsen; T Marrie
Journal:  Can Fam Physician       Date:  1998-02       Impact factor: 3.275

4.  Cefadroxil-Induced Clostridium difficile Infection Following Total Knee Arthroplasty.

Authors:  Nathan Angerett; Christopher Ferguson; Michael Kahan; Devin Fitz; Richard Hallock
Journal:  Arthroplast Today       Date:  2022-10-12

Review 5.  Rational prescribing for postmenopausal urogenital complaints.

Authors:  I Milsom
Journal:  Drugs Aging       Date:  1996-08       Impact factor: 3.923

Review 6.  Bacteremia in the elderly.

Authors:  J P Richardson
Journal:  J Gen Intern Med       Date:  1993-02       Impact factor: 5.128

Review 7.  Bacteraemia in the very old. Features and treatment.

Authors:  L Leibovici
Journal:  Drugs Aging       Date:  1995-06       Impact factor: 3.923

8.  Novel vaccine antigen combinations elicit protective immune responses against Escherichia coli sepsis.

Authors:  Melha Mellata; Natalie M Mitchell; Florian Schödel; Roy Curtiss; Gerald B Pier
Journal:  Vaccine       Date:  2015-12-18       Impact factor: 3.641

Review 9.  Clinical implications of positive blood cultures.

Authors:  C S Bryan
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

10.  Escherichia coli bacteraemia in adults: age-related differences in clinical and bacteriological characteristics, and outcome.

Authors:  C Roubaud Baudron; X Panhard; O Clermont; F Mentré; B Fantin; E Denamur; A Lefort
Journal:  Epidemiol Infect       Date:  2014-02-20       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.